Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23169518 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia (ALL)
Intervention: Drug: Marqibo® (vincristine sulfate liposomes injection)

Indicates status has not been verified in more than two years